BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance

  LabCorp today announced results for the third quarter ended September 30, 2017, and increased its 2017 guidance.

  October 25, 2017

   · 

  25 min read
• Biotech Bay

  Veeva Announces Oncology Data Solution to Identify and Engage Scientific Leaders

  Veeva Systems today announced Veeva Oncology Link, an enterprise data solution to centralize insights and intelligence on scientific leaders in oncology.

  October 25, 2017

   · 

  4 min read
• Policy

  Clongen Receive CAP Accreditation

  Clongen announced that the clinical laboratory received accreditation from the CAP.

  October 25, 2017

   · 

  2 min read
• Business

  KNOW Bio Strengthens Leadership With the Addition of Four New Board Members

  KNOW Bio today announced the addition of Haywood Cochrane, Phil Hodges, Harry Smith, and Anne Whitaker to its Board of Managers.

  October 25, 2017

   · 

  5 min read
• BioForest

  Alligator Bioscience Aptevo Therapeutics: Tumor Antigen 5T4 Associated with Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527

  Alligator Bioscience and Aptevo today announced further details of the companies’ collaboration on ALG.APV-526, a bispecific antibody targeting 4-1BB and a tumor antigen, now identified as 5T4, which is found on various types of cancer cells.

  October 25, 2017

   · 

  6 min read
• Business

  Amerigen and Biophore Collaborate on Penicillamine Generics

  Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant’s Cuprimine and other penicillamine based generic products to the U.S. market using active pharmaceutical ingredient supplied by Biophore from India.

  October 25, 2017

   · 

  1 min read
• Genetown

  Landmark Study Evaluates Long-Term Results of BTL Vanquish Technology Four Years Post-Treatment

  BTL Aesthetics is excited to share the findings of a newly published study that boasts long lasting benefits of noninvasive, radiofrequency energy-as used in the breakthrough BTL Vanquish and Vanquish ME devices-to achieve abdominal circumferential reduction.

  October 25, 2017

   · 

  2 min read
• QIAGEN and ICMP Launch Next-Generation DNA Testing Solutions for Identifying Missing Persons

  The ICMP today announced the launch of a cutting-edge NGS workflow created in collaboration with QIAGEN N.V. for ICMP’s missing persons DNA identification laboratory in The Hague.

  October 25, 2017

   · 

  1 min read
• Business

  ShangPharma Innovation Names Two Executives-in-Residence

  ShangPharma announced the appointment of Dirk G. Brockstedt, Ph.D., and Benson Tsang, MBA, to its Executive-In-Residence (EIR) team.

  October 25, 2017

   · 

  2 min read
• Business

  Penumbra Schedules Third Quarter 2017 Earnings Release and Conference Call for November 7, 2017 at 5:00 PM Eastern Time

  Penumbra today announced that it will host a conference call to discuss financial results for the third quarter 2017 after market close on Tuesday, November 7, 2017 at 5:00 PM Eastern Time. A press release with third quarter 2017 financial results will be issued after market close that day.

  October 25, 2017

   · 

  1 min read